Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-κB pathway

Sun,Ning; Wang,Hui; Wang,Lin

doi:10.3892/mmr.2016.5535

Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-κB pathway

Authors:
- Ning Sun
- Hui Wang
- Lin Wang
View Affiliations

Affiliations: Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin Geriatrics Institute, Tianjin 300052, P.R. China, Department of Geriatrics, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
Published online on: July 20, 2016 https://doi.org/10.3892/mmr.2016.5535
Pages: 2764-2770

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase (iNOS) and inflammation in a mouse model of myocardial ischemia/reperfusion injury (MIRI). In addition, the study aimed to determine its underlying mechanisms. A mouse model of MIRI was used in vivo, in order to ascertain the protective effects of ghrelin on MIRI. Commercial kits were used to measure the serum levels of creatine kinase (CK) and lactate dehydrogenase (LDH) in MIRI mice. Furthermore, Evan's Blue-triphenyltetrazolium chloride solution was used to analyze the protective effects of ghrelin against infarct size in MIRI mice. The underlying mechanisms were determined by measuring MIRI-induced tumor necrosis factor (TNF)‑α, interleukin (IL)‑6, superoxide dismutase (SOD), glutathione (GSH), GSH-peroxidase (GSH‑PX), malondialdehyde (MDA) and caspase‑3/caspase‑9 activities, and iNOS, high mobility group box 1 (HMGB1), Toll‑like receptor 4 (TLR4) and nuclear factor (NF)‑κB protein expression in MIRI mice. The results demonstrated that MIRI led to an increase in infarct size; CK, LDH, TNF‑α, IL‑6, MDA, caspase‑3 and caspase-9 serum levels; and iNOS protein expression. MIRI resulted in inhibition of SOD, FSH and GSH‑PX levels. Conversely, these alterations were significantly inhibited following treatment with ghrelin. In addition, the protective effects of ghrelin against MIRI suppressed HMGB1, TLR4 and NF‑κB protein expression in MIRI mice. The present study revealed that ghrelin exerted protective effects against oxidative stress, iNOS and inflammation in MIRI mice via the HMGB1/TLR4/NF-κB pathway.

View Figures

View References

1	Garcia Gómez-Heras S, Alvarez-Ayuso L, Torralba Arranz A and Fernandez-Garcia H: Purkinje fibers after myocardial ischemia-reperfusion. Histol Histopathol. 30:841–853. 2015.PubMed/NCBI
2	Smiley D, Smith MA, Carreira V, Jiang M, Koch SE, Kelley M, Rubinstein J, Jones WK and Tranter M: Increased fibrosis and progression to heart failure in MRL mice following ischemia/reperfusion injury. Cardiovasc Pathol. 23:327–334. 2014. View Article : Google Scholar : PubMed/NCBI
3	Zhao J, Wang F, Zhang Y, Jiao L, Lau WB, Wang L, Liu B, Gao E, Koch WJ, Ma XL and Wang Y: Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition. Circulation. 128(Suppl 1): S121–S129. 2013. View Article : Google Scholar : PubMed/NCBI
4	Xue L, Wu Z, Ji XP, Gao XQ and Guo YH: Effect and mechanism of salvianolic acid B on the myocardial ischemia-reperfusion injury in rats. Asian Pac J Trop Med. 7:280–284. 2014. View Article : Google Scholar : PubMed/NCBI
5	Park SY, Lee SW, Kim HY, Lee WS, Hong KW and Kim CD: HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation. Eur J Immunol. 45:1216–1227. 2015. View Article : Google Scholar
6	Kornblit B, Munthe-Fog L, Madsen HO, Strom J, Vindelov L and Garred P: Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care. 12:R832008. View Article : Google Scholar : PubMed/NCBI
7	Ibrahim ZA, Armour CL, Phipps S and Sukkar MB: RAGE and TLRs: Relatives, friends or neighbours? Mol Immunol. 56:739–744. 2013. View Article : Google Scholar : PubMed/NCBI
8	Muller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, Batterham RL, Benoit SC, Bowers CY, Broglio F, et al: Ghrelin. Mol Metab. 4:437–460. 2015. View Article : Google Scholar : PubMed/NCBI
9	Jonsson E: The role of ghrelin in energy balance regulation in fish. Gen Comp Endocrinol. 187:79–85. 2013. View Article : Google Scholar : PubMed/NCBI
10	Koyuturk M, Sacan O, Karabulut S, Turk N and Bolkent S, Yanardag R and Bolkent S: The role of ghrelin on apoptosis, cell proliferation and oxidant-antioxidant system in the liver of neonatal diabetic rats. Cell Biol Int. 39:834–841. 2015. View Article : Google Scholar : PubMed/NCBI
11	Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, Li HT and Wang T: Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides. 30:2286–2291. 2009. View Article : Google Scholar : PubMed/NCBI
12	Matsumoto A, Yamafuji M, Tachibana T, Nakabeppu Y, Noda M and Nakaya H: Oral 'hydrogen water' induces neuroprotective ghrelin secretion in mice. Sci Rep. 3:32732013. View Article : Google Scholar : PubMed/NCBI
13	Wang J, Yang H, Hu X, Fu W, Xie J, Zhou X, Xu W and Jiang H: Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo. J Surg Res. 183:509–516. 2013. View Article : Google Scholar : PubMed/NCBI
14	King AL and Lefer DJ: Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury. Exp Physiol. 96:840–846. 2011. View Article : Google Scholar : PubMed/NCBI
15	Ekeløf S, Rosenberg J, Jensen JS and Gögenur I: Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: A systematic review. J Cardiovasc Transl Res. 7:570–580. 2014. View Article : Google Scholar : PubMed/NCBI
16	Ruiz-Meana M and Garcia-Dorado D: Translational cardiovascular medicine (II). Pathophysiology of ischemia-reperfusion injury: New therapeutic options for acute myocardial infarction. Rev Esp Cardiol. 62:199–209. 2009. View Article : Google Scholar : PubMed/NCBI
17	Quintana M, Kahan T and Hjemdahl P: Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent. Am J Cardiovasc Drugs. 4:159–167. 2004. View Article : Google Scholar : PubMed/NCBI
18	Ramasamy R, Yan SF and Schmidt AM: Stopping the primal RAGE reaction in myocardial infarction: Capturing adaptive responses to heal the heart? Circulation. 117:3165–3167. 2008. View Article : Google Scholar : PubMed/NCBI
19	Wang Q, Cheng Y, Xue FS, Yuan YJ, Xiong J, Li RP, Liao X and Liu JH: Postconditioning with vagal stimulation attenuates local and systemic inflammatory responses to myocardial ischemia reperfusion injury in rats. Inflamm Res. 61:1273–1282. 2012. View Article : Google Scholar
20	Wang W, Bansal S, Falk S, Ljubanovic D and Schrier R: Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am J Physiol Renal Physiol. 297:F1032–F1037. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ercan S, Basaranlar G, Gungor NE, Kencebay C, Sahin P, Celik-Ozenci C and Derin N: Ghrelin inhibits sodium metabisulfite induced oxidative stress and apoptosis in rat gastric mucosa. Food Chem Toxicol. 56:154–161. 2013. View Article : Google Scholar : PubMed/NCBI
22	Herzog C, Lorenz A, Gillmann HJ, Chowdhury A, Larmann J, Harendza T, Echtermeyer F, Müller M, Schmitz M, Stypmann J, et al: Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling. Cardiovasc Res. 101:400–410. 2014. View Article : Google Scholar
23	Kwak MS, Lim M, Lee YJ, Lee HS, Kim YH, Youn JH, Choi JE and Shin JS: HMGB1 binds to lipoteichoic acid and enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2. J Innate Immun. 7:405–416. 2015. View Article : Google Scholar
24	Liu Q, Wang J, Liang Q, Wang D, Luo Y, Li J, Janicki JS and Fan D: Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation. Exp Biol Med (Maywood). 239:376–384. 2014. View Article : Google Scholar
25	Liu X, Xiao Q, Zhao K and Gao Y: Ghrelin inhibits high glucose-induced PC12 cell apoptosis by regulating TLR4/NF-kappaB pathway. Inflammation. 36:1286–1294. 2013. View Article : Google Scholar : PubMed/NCBI
26	Song R, Ao L, Zhao KS, Zheng D, Venardos N, Fullerton DA and Meng X: Soluble biglycan induces the production of ICAM-1 and MCP-1 in human aortic valve interstitial cells through TLR2/4 and the ERK1/2 pathway. Inflamm Res. 63:703–710. 2014. View Article : Google Scholar : PubMed/NCBI
27	Hao H, Gufu H, Lei F, Dang L and Zhongliang Y: Baicalin suppresses expression of TLR2/4 and NF-κB in chlamydia trachomatis-infected mice. Immunopharmacol Immunotoxicol. 34:89–94. 2012. View Article : Google Scholar
28	Tu XK, Yang WZ, Chen JP, Chen Y, Ouyang LQ, Xu YC and Shi SS: Curcumin inhibits TLR2/4-NF-κB signaling pathway and attenuates brain damage in permanent focal cerebral ischemia in rats. Inflammation. 37:1544–1551. 2014. View Article : Google Scholar : PubMed/NCBI
29	Rezaeian F, Wettstein R, Scheuer C, Bäumker K, Bächle A, Vollmar B, Menger MD and Harder Y: Ghrelin protects musculocutaneous tissue from ischemic necrosis by improving microvascular perfusion. Am J Physiol Heart Circ Physiol. 302:H603–H610. 2012. View Article : Google Scholar